Sitrin Capital Management LLC Grows Stock Position in Agilent Technologies, Inc. $A

Key Points

• Sitrin Capital Management LLC increased its stake in Agilent Technologies by 34.3% in Q2, now holding 47,356 shares valued at approximately $5.59 million.
• Agilent Technologies reported earnings of $1.37 EPS for the last quarter, meeting analysts' expectations, with a year-over-year revenue increase of 10.1%.
• The company announced a quarterly dividend of $0.248 per share to be paid on October 22nd, representing an annualized yield of 0.7%.

Sitrin Capital Management LLC raised its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 34.3% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 47,356 shares of the medical research company's stock after purchasing an additional 12,097 shares during the quarter. Agilent Technologies accounts for approximately 2.9% of Sitrin Capital Management LLC's portfolio, making the stock its 19th largest position. Sitrin Capital Management LLC's holdings in Agilent Technologies were worth $5,588,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Dohj LLC raised its position in Agilent Technologies by 12.6% in the second quarter. Dohj LLC now owns 6,581 shares of the medical research company's stock valued at $777,000 after purchasing an additional 738 shares during the period. Shell Asset Management Co. raised its position in Agilent Technologies by 6.5% in the second quarter. Shell Asset Management Co. now owns 20,772 shares of the medical research company's stock valued at $2,451,000 after purchasing an additional 1,271 shares during the period. Godsey & Gibb Inc. raised its position in Agilent Technologies by 19.8% in the second quarter. Godsey & Gibb Inc. now owns 166,664 shares of the medical research company's stock valued at $19,668,000 after purchasing an additional 27,520 shares during the period. KLP Kapitalforvaltning AS raised its position in Agilent Technologies by 1.8% in the second quarter. KLP Kapitalforvaltning AS now owns 103,849 shares of the medical research company's stock valued at $12,255,000 after purchasing an additional 1,800 shares during the period. Finally, KPP Advisory Services LLC raised its position in Agilent Technologies by 11.5% in the second quarter. KPP Advisory Services LLC now owns 3,741 shares of the medical research company's stock valued at $442,000 after purchasing an additional 385 shares during the period.

Agilent Technologies Stock Performance

Shares of A stock opened at $140.81 on Thursday. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The firm has a fifty day moving average price of $124.07 and a 200 day moving average price of $116.81. The company has a market cap of $39.92 billion, a P/E ratio of 33.05, a PEG ratio of 4.52 and a beta of 1.26. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting analysts' consensus estimates of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company's revenue was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies's payout ratio is presently 23.24%.

Analyst Ratings Changes

A number of analysts have issued reports on A shares. Barclays boosted their target price on Agilent Technologies from $125.00 to $150.00 and gave the company an "equal weight" rating in a research report on Thursday, October 2nd. UBS Group upgraded shares of Agilent Technologies from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $130.00 to $170.00 in a research note on Wednesday. Weiss Ratings restated a "hold (c)" rating on shares of Agilent Technologies in a research note on Wednesday. Wells Fargo & Company boosted their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an "overweight" rating in a research note on Monday, September 15th. Finally, Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a research note on Wednesday. They issued a "buy" rating and a $165.00 price target for the company. Eight analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $147.92.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.